Attention-Deficit Hyperactivity Disorder (ADHD) safe “treatment” Essay Assignment Paper

The pharmaceutical industry, working with the government and organized psychiatry, claim that such drugs as Ritalin, are a safe “treatment” for ADHD. School systems and courts have pressured and even forced parents to give stimulant drugs to their children. But hidden behind the well-oiled public relations machine is a potentially devastating reality. The problem with ADHD or ADD is already not whether or not ADHD is a subtype of ADD, but rather the problem is whether or not we should be medicating our children with drugs such as Ritalin.

Kindly order now for a custom-written, completely unique essay paper that is free of plagiarism! on Attention-Deficit Hyperactivity Disorder (ADHD) safe “treatment” Essay Assignment Paper from Best Nursing Writers

Questions like the following often arise when discussing the issue: Are the side effects worth getting our children under control? Are all the children who are on Ritalin on it for just cause or are the drugs being abused? What does the future hold for these children who are using Ritalin and other stimulants? All these questions leave a lot parents wondering if they should put there young child on medications and what it will do to their future.
Millions of children are prescribed the stimulant drugs such as Ritalin, Adderall, Concerta and Metadate for Attention-Deficit Hyperactivity Disorder (ADHD) in the hope of controlling behaviors described as hyperactivity, impulsivity and inattention. These medications decrease restlessness, improve attention span, increase the ability to focus, decrease aggressive outbursts and improve social interaction.Ritalin Abuse Assignment Paper They are thought to work by adjusting the brain’s chemical balance and reversing under-arousal, possibly by increasing the availability of certain neurotransmitters. About 75 % of children with ADHD respond well to stimulant medication with improved attention at school and increased academic productivity (Kidd, 2000).